In this journal review, we discuss how tezepelumab reduced nasal polyp size, alleviated congestion & decreased the need for surgery over 52 weeks. Listen for the full breakdown.

ACAAI President Dr. James Tracy shares how the College supports allergy patients and clinicians, offering insights into leadership, advocacy, and emerging technologies like AI.

Understand how cultural beliefs, language barriers, and skin color impact diagnosing and treating chronic hives (urticaria) in Latinx patients.

Understand the risks of systemic and topical steroid use in eczema treatment, steroid withdrawal, safer alternatives, and tips for skin of color.

Learn why long-term oral steroid overuse in asthma is dangerous, how to know if you're overusing them, and how to reduce flare-ups with safer treatments.

Learn what "control" means in managing Type 2 inflammation, why it matters, and how to effectively manage asthma, eczema, and allergic conditions.

Can we slow or stop the atopic march? Learn how Type 2 inflammation impacts kids and if treatments like immunotherapy or biologics can change the outcome.

Discover how Type 2 Inflammation connects conditions like asthma, eczema, and nasal polyps to reveal a shared cause and guide better treatment.

Discover the key players in Type 2 inflammation, like Th2 cells, IgE antibodies, and cytokines. Learn how they interact and how they create excess inflammation.